Back to state act
Description
On 24 May 2023, the government of Canada announced an investment of CAD 225 million (USD 165.43 million) in AbCellera's preclinical antibody development facility in Vancouver. The investment is made i...
Sign in to see full description
Intervention Details
Intervention Type
State loan
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
24 May 2023
Revocation date
No revocation date
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 4 products
Threads
See all
This intervention is not part of any Thread yet.